291 related articles for article (PubMed ID: 21629037)
1. Lipid targets during statin treatment in dyslipidemic patients affected by nonalcoholic fatty liver disease.
Maroni L; Guasti L; Castiglioni L; Marino F; Contini S; Macchi V; De Leo A; Gaudio G; Tozzi M; Grandi AM; Cosentino M; Venco A
Am J Med Sci; 2011 Nov; 342(5):383-7. PubMed ID: 21629037
[TBL] [Abstract][Full Text] [Related]
2. Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada.
Gitt AK; Drexel H; Feely J; Ferrières J; Gonzalez-Juanatey JR; Thomsen KK; Leiter LA; Lundman P; da Silva PM; Pedersen T; Wood D; Jünger C; Dellea PS; Sazonov V; Chazelle F; Kastelein JJ;
Eur J Prev Cardiol; 2012 Apr; 19(2):221-30. PubMed ID: 21450578
[TBL] [Abstract][Full Text] [Related]
3. Under-prescription of statins in patients with non-alcoholic fatty liver disease.
Del Ben M; Baratta F; Polimeni L; Pastori D; Loffredo L; Averna M; Violi F; Angelico F
Nutr Metab Cardiovasc Dis; 2017 Feb; 27(2):161-167. PubMed ID: 27914698
[TBL] [Abstract][Full Text] [Related]
4. Pitavastatin: novel effects on lipid parameters.
Chapman MJ
Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
[TBL] [Abstract][Full Text] [Related]
5. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
Cziraky MJ; Watson KE; Talbert RL
J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy with statins and omega-3 fatty acids.
Nambi V; Ballantyne CM
Am J Cardiol; 2006 Aug; 98(4A):34i-38i. PubMed ID: 16919515
[TBL] [Abstract][Full Text] [Related]
7. Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD.
Bril F; Sninsky JJ; Baca AM; Superko HR; Portillo Sanchez P; Biernacki D; Maximos M; Lomonaco R; Orsak B; Suman A; Weber MH; McPhaul MJ; Cusi K
J Clin Endocrinol Metab; 2016 Feb; 101(2):644-52. PubMed ID: 26672634
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
[TBL] [Abstract][Full Text] [Related]
9. Weight loss, dietary advice and statin therapy in non-alcoholic fatty liver disease: a retrospective study.
Riley P; Sudarshi D; Johal M; Benedict A; Panteli J; Crook M; O'Donohue J
Int J Clin Pract; 2008 Mar; 62(3):374-81. PubMed ID: 18201181
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of combined statin plus omega-3 fatty acid therapy for mixed dyslipidemia.
Barter P; Ginsberg HN
Am J Cardiol; 2008 Oct; 102(8):1040-5. PubMed ID: 18929706
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of combined ezetimibe/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease.
Abel T; Fehér J; Dinya E; Eldin MG; Kovács A
Med Sci Monit; 2009 Dec; 15(12):MS6-11. PubMed ID: 19946244
[TBL] [Abstract][Full Text] [Related]
12. DemographIc Assessment and EValuation of DEgree of Lipid Control in High Risk Indian DySlipidemia PatiEnts (DIVERSE Study).
Malhotra N; Keshan MK; Agarwal A; Kumar RA; Trailokya A; Dalvi K; Talele S
J Assoc Physicians India; 2016 Apr; 64(4):38-46. PubMed ID: 27734640
[TBL] [Abstract][Full Text] [Related]
13. Association between dyslipidemia and vascular events in patients treated with statins: report from the UK General Practice Research Database.
Sazonov V; Beetsch J; Phatak H; Wentworth C; Evans M
Atherosclerosis; 2010 Jan; 208(1):210-6. PubMed ID: 19766999
[TBL] [Abstract][Full Text] [Related]
14. Suboptimal treatment of dyslipidemia in patients with nonalcoholic fatty liver disease.
Khoo S; Wong VW; Goh GB; Fan J; Chan WK; Seto WK; Chow WC
J Gastroenterol Hepatol; 2020 Feb; 35(2):320-325. PubMed ID: 31336392
[TBL] [Abstract][Full Text] [Related]
15. Frequency of Attainment of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol Goals in Cardiovascular Clinical Practice (from the National Cardiovascular Data Registry PINNACLE Registry).
Spinler SA; Cziraky MJ; Willey VJ; Tang F; Maddox TM; Thomas T; Dueñas GG; Virani SS;
Am J Cardiol; 2015 Aug; 116(4):547-53. PubMed ID: 26089010
[TBL] [Abstract][Full Text] [Related]
16. Dyslipidemia in patients with nonalcoholic fatty liver disease.
Chatrath H; Vuppalanchi R; Chalasani N
Semin Liver Dis; 2012 Feb; 32(1):22-9. PubMed ID: 22418885
[TBL] [Abstract][Full Text] [Related]
17. Achieving vascular risk factor targets: a survey of a London general practice.
Levine AP; Mikhailidis DP; Moross T; Benson K; Gor M
Angiology; 2008; 59(1):36-46. PubMed ID: 18319220
[TBL] [Abstract][Full Text] [Related]
18. Total lipid management and cardiovascular disease in the dyslipidemia international study.
Ferrières J; Amber V; Crisan O; Chazelle F; Jünger C; Wood D
Cardiology; 2013; 125(3):154-63. PubMed ID: 23736147
[TBL] [Abstract][Full Text] [Related]
19. Dyslipidemia: management using optimal lipid-lowering therapy.
Ito MK
Ann Pharmacother; 2012 Oct; 46(10):1368-81. PubMed ID: 23032652
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of statin-ezetimibe combination to reduce the care gap in dyslipidemia management in patients with a high risk of atherosclerotic disease.
Teoh H; Mendelsohn AA; Goodman SG; Jaffer S; Chen RY; Tjia S; Theriault L; Langer A; Leiter LA;
Am J Cardiol; 2009 Sep; 104(6):798-804. PubMed ID: 19733714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
